Pharma Industry
Industry: Email Alert RSS FeedEfalizumab for eczema
Journal of Drugs in Dermatology, May, 2006
This study is currently recruiting patients. Verified by University of Medicine and Dentistry New Jersey. Sponsors and collaborators: University of Medicine and Dentistry New Jersey and Genentech. The purpose of this study is to demonstrate a measurable improvement on a validated scale in a small population of adult patients with atopic dermatitis (eczema).
Condition Intervention Phase Dermatitis, Atopic Drug: Efalizumab treatment Phase II
Study ID Numbers: 5163
Most RecentPharma Articles
ClinicalTrials.gov Identifier: NCT00146003
COPYRIGHT 2006 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
Brought to you by CBS MoneyWatch.com
- 10 Best Places to Retire
- Companies with the Best 401(k) Plans
- Most Important Document for Your Heirs? It's Not Your Will
- Video: Should You Expect to Retire Rich?
- Over 50? Here's How to Get (and Keep) a Great Job
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
- La anemia falciforme - causas y tratamiento
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
Most Popular Health Publications
Content provided in partnership with http://findarticles.com/source//
Sponsored by Merrill Lynch